We're excited to present LeaVS, a method to scale up learning for protein function models. It is based on the co-design of wet lab experiments and in silico training.

Tests of large language models reveal that they can behave in deceptive and potentially harmful ways. Nature reports on what these results mean for the future of AI. 🧪

Check out our latest whitepaper on Digital Transformations and learn how you can apply these technologies to improve your own drug discovery process. aspenbiosciences.com/whitepapers/...

Despite all of the uncertainty in the industry, those two elements continue to be a high priority for investors. They want to know how you're going to get the rest of your pipeline across the finish the line in the most capital efficient manner possible.

The past couple of years have been challenging for biotech companies. At #JPM2025, investors were looking for two things: Phase II results, and a #DigitalTransformation story that showed how #AI, #automation and advanced analytics would be used to advance early stage programs into the clinic.

The race for funding is real, but chaos isn't a plan. It's time to swap out the monkeys for a real digital transformation roadmap.

aspenbiosciences.com/whitepapers/...

Does your drug discovery strategy feel like... AI-fueled robot monkeys hammering away and hoping for a miracle? 🐒🤖

youtu.be/R0n__5HOOe8?...

#Biotech #DrugDiscovery #Pharma #DigitalTransformation #AI #Automation #Science

for 10 years I have been giving an introduction into protein structure at the Zuyd applied university (two short lectures, two short practicals).

We have been using Proteopedia, because it is Open, it is free, it is interactive, and is powered by Jmol […]

[Original post on social.edu.nl]

This is the new reality of drug discovery. What are your six impossible things?

For scientists, it’s :

- Planning new discovery programs

- Coordinating work with scientists across multiple labs and CROs

- Running synthesis requests and assays

- Generating, collecting, and analyzing all the data

...and then doing it all over again.

The pandemic taught us we can do six impossible things before breakfast —like getting new medicines to patients faster by collaborating across time zones 24/7.

Now, that "impossible" pace is the daily routine.

#DrugDiscovery #Biotech #Science #Rnd #Pharma #Innovation

Watch the video on our YouTube channel for a brief preview.
youtu.be/6fPV1bIttnA?...

Our latest whitepaper contains case studies, examples and implementation strategies that you can apply to improve your drug discovery operations. aspenbiosciences.com/whitepapers/...

#DigitalTransformation is the process of applying technologies like #AI, #automation and advanced analytics to fundamentally change #DrugDiscovery, in ways that measurably reduce costs and timelines, improve capital efficiency and create a more lean and agile research organization.

In our series "Across The Great Divide" we're taking a look at the "Great Divide" between drug discovery and drug development projects and how drug discovery project planning can improve the capital efficiency of your programs and the…

https://aspenbiosciences.com/across-the-great-divide-part-2/

Chemists Stuart Schreiber of Harvard University and Arena BioWorks and Peter Schultz of @scripps.edu will split the 2025 Welch Award in Chemistry for their work in the field of chemical biology. cen.acs.org/people/award... #chemsky🧪

Health secretary RFK Jr. names familiar culprits for the "sickest generation," even where evidence is lacking

www.statnews.com/2025/05/22/r...

The full panel discussion from our “Era of TechBio” event at #JPM25 is online! Hear from leading voices at the intersection of investment, technology & healthcare discussing the latest wins & remaining obstacles & how breakthroughs like LLMs & AI agents are allowing us to scale. youtu.be/GM9l8Pi8CYs